Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus

Introduction: Weight loss and increased physical activity interventions are commonly recommended for individuals with type 2 diabetes (T2D) and overweight or obesity. We examined the impact of randomization to an intensive lifestyle intervention (ILI) on trajectories of cognitive function over 10 ye...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dementia and geriatric cognitive disorders 2021-10, Vol.50 (3), p.237-249
Hauptverfasser: Hayden, Kathleen M., Neiberg, Rebecca H., Evans, Joni K., Luchsinger, José A., Carmichael, Owen, Dutton, Gareth R., Johnson, Karen C., Kahn, Steven E., Rapp, Stephen R., Yasar, Sevil, Espeland, Mark A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 249
container_issue 3
container_start_page 237
container_title Dementia and geriatric cognitive disorders
container_volume 50
creator Hayden, Kathleen M.
Neiberg, Rebecca H.
Evans, Joni K.
Luchsinger, José A.
Carmichael, Owen
Dutton, Gareth R.
Johnson, Karen C.
Kahn, Steven E.
Rapp, Stephen R.
Yasar, Sevil
Espeland, Mark A.
description Introduction: Weight loss and increased physical activity interventions are commonly recommended for individuals with type 2 diabetes (T2D) and overweight or obesity. We examined the impact of randomization to an intensive lifestyle intervention (ILI) on trajectories of cognitive function over 10 years in a cohort of participants in a randomized clinical trial who had T2D and overweight/obesity at baseline. Methods: Participants aged 45–76 years were enrolled in 2001–2004 and were randomized to the ILI or a diabetes support and education (DSE) condition. Cognitive function was assessed in 3,938 participants at up to 4 time points 8–18 years after randomization. General linear mixed effects models examined cognitive trajectories over time. Subgroup analyses focused on sex, individuals with baseline body mass index >30, those carrying the APOE ε4 allele, and those with a baseline history of cardiovascular disease (CVD). Results: Overall, there were no differences in the rate of cognitive decline by intervention arm. Subgroup analyses showed that participants who had a baseline history of CVD and were randomized to the ILI arm of the study performed significantly worse on the Stroop Color Word Test than those in the DSE arm. Discussion/Conclusions: The ILI did not result in preserved cognitive function or slower rates of cognitive decline in this cohort of individuals who had T2D and were overweight or obese at baseline.
doi_str_mv 10.1159/000517160
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A709901216</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A709901216</galeid><sourcerecordid>A709901216</sourcerecordid><originalsourceid>FETCH-LOGICAL-c522t-8bb922be0c0b1dd23f31e7c5fa5c817ce90607695489f1a4f2a79ecf097f0e1b3</originalsourceid><addsrcrecordid>eNptks1qGzEUhYfS0qRpF92XIgiUdDGJpPnRzKYQnLQ12HjjLroSGs3VjNKx5EgaB79JHzdynZoYggQSut85cK5uknwk-JKQor7CGBeEkRK_Sk5JTklaVzR__e-O0wrj6iR55_1dxFhR1m-TkyzPCcUFO03-zqATcousQgIRnP4G4dB8HIJu7Upog2ZagQ_bAdDUBHAbMEFbg-IOPaCJ7YwOegNo6cQdyGCdBr9zm5pWb3Q7isGjBx16tNiAewDd9eFq0YDXYYuEadFyuwZE0Y0WDYQoncMw6DD698kbFbXw4ek8S359v11OfqazxY_p5HqWyoLSkFZNU1PaAJa4IW1LM5URYLJQopAVYRJqXGJW1kVe1YqIXFHBapAK10xhIE12lnzb-67HZgWtjPmcGPja6ZVwW26F5scVo3ve2Q2vigxXFY4GF08Gzt6PsVd8pb2MKYQBO3pOizLLKWM0i-j5Hu3EAFwbZaOj3OH8muG6xoSSMlKXL1BxtbDS0hpQOr4fCb48E_QghtB7O4y7j_LH4Nc9KJ313oE6xCSY7yaJHyYpsp-f9-VA_h-dCHzaA3-E68AdgIP-_MXyze18T_B1q7JHmCbYzQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563427723</pqid></control><display><type>article</type><title>Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus</title><source>Karger Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Hayden, Kathleen M. ; Neiberg, Rebecca H. ; Evans, Joni K. ; Luchsinger, José A. ; Carmichael, Owen ; Dutton, Gareth R. ; Johnson, Karen C. ; Kahn, Steven E. ; Rapp, Stephen R. ; Yasar, Sevil ; Espeland, Mark A.</creator><creatorcontrib>Hayden, Kathleen M. ; Neiberg, Rebecca H. ; Evans, Joni K. ; Luchsinger, José A. ; Carmichael, Owen ; Dutton, Gareth R. ; Johnson, Karen C. ; Kahn, Steven E. ; Rapp, Stephen R. ; Yasar, Sevil ; Espeland, Mark A. ; Action for Health in Diabetes (Look AHEAD) Research Group ; and the Action for Health in Diabetes (Look AHEAD) Research Group</creatorcontrib><description>Introduction: Weight loss and increased physical activity interventions are commonly recommended for individuals with type 2 diabetes (T2D) and overweight or obesity. We examined the impact of randomization to an intensive lifestyle intervention (ILI) on trajectories of cognitive function over 10 years in a cohort of participants in a randomized clinical trial who had T2D and overweight/obesity at baseline. Methods: Participants aged 45–76 years were enrolled in 2001–2004 and were randomized to the ILI or a diabetes support and education (DSE) condition. Cognitive function was assessed in 3,938 participants at up to 4 time points 8–18 years after randomization. General linear mixed effects models examined cognitive trajectories over time. Subgroup analyses focused on sex, individuals with baseline body mass index &gt;30, those carrying the APOE ε4 allele, and those with a baseline history of cardiovascular disease (CVD). Results: Overall, there were no differences in the rate of cognitive decline by intervention arm. Subgroup analyses showed that participants who had a baseline history of CVD and were randomized to the ILI arm of the study performed significantly worse on the Stroop Color Word Test than those in the DSE arm. Discussion/Conclusions: The ILI did not result in preserved cognitive function or slower rates of cognitive decline in this cohort of individuals who had T2D and were overweight or obese at baseline.</description><identifier>ISSN: 1420-8008</identifier><identifier>ISSN: 1421-9824</identifier><identifier>EISSN: 1421-9824</identifier><identifier>DOI: 10.1159/000517160</identifier><identifier>PMID: 34412057</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Analysis ; Apolipoproteins ; Cognition ; Diabetes Mellitus, Type 2 - therapy ; Exercise ; Humans ; Life Style ; Obesity ; Obesity - therapy ; Overweight - therapy ; Research Article ; Type 2 diabetes</subject><ispartof>Dementia and geriatric cognitive disorders, 2021-10, Vol.50 (3), p.237-249</ispartof><rights>2021 S. Karger AG, Basel</rights><rights>2021 S. Karger AG, Basel.</rights><rights>COPYRIGHT 2021 S. Karger AG</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c522t-8bb922be0c0b1dd23f31e7c5fa5c817ce90607695489f1a4f2a79ecf097f0e1b3</citedby><cites>FETCH-LOGICAL-c522t-8bb922be0c0b1dd23f31e7c5fa5c817ce90607695489f1a4f2a79ecf097f0e1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34412057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hayden, Kathleen M.</creatorcontrib><creatorcontrib>Neiberg, Rebecca H.</creatorcontrib><creatorcontrib>Evans, Joni K.</creatorcontrib><creatorcontrib>Luchsinger, José A.</creatorcontrib><creatorcontrib>Carmichael, Owen</creatorcontrib><creatorcontrib>Dutton, Gareth R.</creatorcontrib><creatorcontrib>Johnson, Karen C.</creatorcontrib><creatorcontrib>Kahn, Steven E.</creatorcontrib><creatorcontrib>Rapp, Stephen R.</creatorcontrib><creatorcontrib>Yasar, Sevil</creatorcontrib><creatorcontrib>Espeland, Mark A.</creatorcontrib><creatorcontrib>Action for Health in Diabetes (Look AHEAD) Research Group</creatorcontrib><creatorcontrib>and the Action for Health in Diabetes (Look AHEAD) Research Group</creatorcontrib><title>Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus</title><title>Dementia and geriatric cognitive disorders</title><addtitle>Dement Geriatr Cogn Disord</addtitle><description>Introduction: Weight loss and increased physical activity interventions are commonly recommended for individuals with type 2 diabetes (T2D) and overweight or obesity. We examined the impact of randomization to an intensive lifestyle intervention (ILI) on trajectories of cognitive function over 10 years in a cohort of participants in a randomized clinical trial who had T2D and overweight/obesity at baseline. Methods: Participants aged 45–76 years were enrolled in 2001–2004 and were randomized to the ILI or a diabetes support and education (DSE) condition. Cognitive function was assessed in 3,938 participants at up to 4 time points 8–18 years after randomization. General linear mixed effects models examined cognitive trajectories over time. Subgroup analyses focused on sex, individuals with baseline body mass index &gt;30, those carrying the APOE ε4 allele, and those with a baseline history of cardiovascular disease (CVD). Results: Overall, there were no differences in the rate of cognitive decline by intervention arm. Subgroup analyses showed that participants who had a baseline history of CVD and were randomized to the ILI arm of the study performed significantly worse on the Stroop Color Word Test than those in the DSE arm. Discussion/Conclusions: The ILI did not result in preserved cognitive function or slower rates of cognitive decline in this cohort of individuals who had T2D and were overweight or obese at baseline.</description><subject>Analysis</subject><subject>Apolipoproteins</subject><subject>Cognition</subject><subject>Diabetes Mellitus, Type 2 - therapy</subject><subject>Exercise</subject><subject>Humans</subject><subject>Life Style</subject><subject>Obesity</subject><subject>Obesity - therapy</subject><subject>Overweight - therapy</subject><subject>Research Article</subject><subject>Type 2 diabetes</subject><issn>1420-8008</issn><issn>1421-9824</issn><issn>1421-9824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptks1qGzEUhYfS0qRpF92XIgiUdDGJpPnRzKYQnLQ12HjjLroSGs3VjNKx5EgaB79JHzdynZoYggQSut85cK5uknwk-JKQor7CGBeEkRK_Sk5JTklaVzR__e-O0wrj6iR55_1dxFhR1m-TkyzPCcUFO03-zqATcousQgIRnP4G4dB8HIJu7Upog2ZagQ_bAdDUBHAbMEFbg-IOPaCJ7YwOegNo6cQdyGCdBr9zm5pWb3Q7isGjBx16tNiAewDd9eFq0YDXYYuEadFyuwZE0Y0WDYQoncMw6DD698kbFbXw4ek8S359v11OfqazxY_p5HqWyoLSkFZNU1PaAJa4IW1LM5URYLJQopAVYRJqXGJW1kVe1YqIXFHBapAK10xhIE12lnzb-67HZgWtjPmcGPja6ZVwW26F5scVo3ve2Q2vigxXFY4GF08Gzt6PsVd8pb2MKYQBO3pOizLLKWM0i-j5Hu3EAFwbZaOj3OH8muG6xoSSMlKXL1BxtbDS0hpQOr4fCb48E_QghtB7O4y7j_LH4Nc9KJ313oE6xCSY7yaJHyYpsp-f9-VA_h-dCHzaA3-E68AdgIP-_MXyze18T_B1q7JHmCbYzQ</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Hayden, Kathleen M.</creator><creator>Neiberg, Rebecca H.</creator><creator>Evans, Joni K.</creator><creator>Luchsinger, José A.</creator><creator>Carmichael, Owen</creator><creator>Dutton, Gareth R.</creator><creator>Johnson, Karen C.</creator><creator>Kahn, Steven E.</creator><creator>Rapp, Stephen R.</creator><creator>Yasar, Sevil</creator><creator>Espeland, Mark A.</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus</title><author>Hayden, Kathleen M. ; Neiberg, Rebecca H. ; Evans, Joni K. ; Luchsinger, José A. ; Carmichael, Owen ; Dutton, Gareth R. ; Johnson, Karen C. ; Kahn, Steven E. ; Rapp, Stephen R. ; Yasar, Sevil ; Espeland, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c522t-8bb922be0c0b1dd23f31e7c5fa5c817ce90607695489f1a4f2a79ecf097f0e1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Apolipoproteins</topic><topic>Cognition</topic><topic>Diabetes Mellitus, Type 2 - therapy</topic><topic>Exercise</topic><topic>Humans</topic><topic>Life Style</topic><topic>Obesity</topic><topic>Obesity - therapy</topic><topic>Overweight - therapy</topic><topic>Research Article</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hayden, Kathleen M.</creatorcontrib><creatorcontrib>Neiberg, Rebecca H.</creatorcontrib><creatorcontrib>Evans, Joni K.</creatorcontrib><creatorcontrib>Luchsinger, José A.</creatorcontrib><creatorcontrib>Carmichael, Owen</creatorcontrib><creatorcontrib>Dutton, Gareth R.</creatorcontrib><creatorcontrib>Johnson, Karen C.</creatorcontrib><creatorcontrib>Kahn, Steven E.</creatorcontrib><creatorcontrib>Rapp, Stephen R.</creatorcontrib><creatorcontrib>Yasar, Sevil</creatorcontrib><creatorcontrib>Espeland, Mark A.</creatorcontrib><creatorcontrib>Action for Health in Diabetes (Look AHEAD) Research Group</creatorcontrib><creatorcontrib>and the Action for Health in Diabetes (Look AHEAD) Research Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Dementia and geriatric cognitive disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hayden, Kathleen M.</au><au>Neiberg, Rebecca H.</au><au>Evans, Joni K.</au><au>Luchsinger, José A.</au><au>Carmichael, Owen</au><au>Dutton, Gareth R.</au><au>Johnson, Karen C.</au><au>Kahn, Steven E.</au><au>Rapp, Stephen R.</au><au>Yasar, Sevil</au><au>Espeland, Mark A.</au><aucorp>Action for Health in Diabetes (Look AHEAD) Research Group</aucorp><aucorp>and the Action for Health in Diabetes (Look AHEAD) Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus</atitle><jtitle>Dementia and geriatric cognitive disorders</jtitle><addtitle>Dement Geriatr Cogn Disord</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>50</volume><issue>3</issue><spage>237</spage><epage>249</epage><pages>237-249</pages><issn>1420-8008</issn><issn>1421-9824</issn><eissn>1421-9824</eissn><abstract>Introduction: Weight loss and increased physical activity interventions are commonly recommended for individuals with type 2 diabetes (T2D) and overweight or obesity. We examined the impact of randomization to an intensive lifestyle intervention (ILI) on trajectories of cognitive function over 10 years in a cohort of participants in a randomized clinical trial who had T2D and overweight/obesity at baseline. Methods: Participants aged 45–76 years were enrolled in 2001–2004 and were randomized to the ILI or a diabetes support and education (DSE) condition. Cognitive function was assessed in 3,938 participants at up to 4 time points 8–18 years after randomization. General linear mixed effects models examined cognitive trajectories over time. Subgroup analyses focused on sex, individuals with baseline body mass index &gt;30, those carrying the APOE ε4 allele, and those with a baseline history of cardiovascular disease (CVD). Results: Overall, there were no differences in the rate of cognitive decline by intervention arm. Subgroup analyses showed that participants who had a baseline history of CVD and were randomized to the ILI arm of the study performed significantly worse on the Stroop Color Word Test than those in the DSE arm. Discussion/Conclusions: The ILI did not result in preserved cognitive function or slower rates of cognitive decline in this cohort of individuals who had T2D and were overweight or obese at baseline.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>34412057</pmid><doi>10.1159/000517160</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-8008
ispartof Dementia and geriatric cognitive disorders, 2021-10, Vol.50 (3), p.237-249
issn 1420-8008
1421-9824
1421-9824
language eng
recordid cdi_gale_infotracmisc_A709901216
source Karger Journals; MEDLINE; Alma/SFX Local Collection
subjects Analysis
Apolipoproteins
Cognition
Diabetes Mellitus, Type 2 - therapy
Exercise
Humans
Life Style
Obesity
Obesity - therapy
Overweight - therapy
Research Article
Type 2 diabetes
title Legacy of a 10-Year Multidomain Lifestyle Intervention on the Cognitive Trajectories of Individuals with Overweight/Obesity and Type 2 Diabetes Mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T13%3A42%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Legacy%20of%20a%2010-Year%20Multidomain%20Lifestyle%20Intervention%20on%20the%20Cognitive%20Trajectories%20of%20Individuals%20with%20Overweight/Obesity%20and%20Type%202%20Diabetes%20Mellitus&rft.jtitle=Dementia%20and%20geriatric%20cognitive%20disorders&rft.au=Hayden,%20Kathleen%20M.&rft.aucorp=Action%20for%20Health%20in%20Diabetes%20(Look%20AHEAD)%20Research%20Group&rft.date=2021-10-01&rft.volume=50&rft.issue=3&rft.spage=237&rft.epage=249&rft.pages=237-249&rft.issn=1420-8008&rft.eissn=1421-9824&rft_id=info:doi/10.1159/000517160&rft_dat=%3Cgale_cross%3EA709901216%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2563427723&rft_id=info:pmid/34412057&rft_galeid=A709901216&rfr_iscdi=true